Details of the Drug Combinations
General Information of This Drug (ID: DMGN4BY)
| Drug Name | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | 
                        Adfeed; Adofeed; Anmetarin; Ansaid; Anside; Antadys; Cebutid; FLP; Flubiprofen; Flugalin; Flurbiprofene; Flurbiprofeno; Flurbiprofenum; Fluriproben; Flurofen; Froben; Ocufen; Ocuflur; Stayban; Yakuban; Zepolas; FLURBIPROFEN SODIUM; Froben Sr; BTS 18322; F0371; FP 70; IN1332; U 27182; Ansaid (TN); Apo-Flurbiprofen; BTS-18322; Flurbiprofene [INN-French]; Flurbiprofeno [INN-Spanish]; Flurbiprofenum [INN-Latin]; Froben (TN); MKS-11; Novo-Flurprofen; Nu-Flurbiprofen; U 27,182; U-27182; L-790,330; Flurbiprofen (JP15/USP/INN); Flurbiprofen [USAN:INN:BAN:JAN]; [+/-]-2-Fluoro-alpha-methyl-4-biphenylacetic acid; (+-)-2-(2-Fluoro-4-biphenylyl)propionic acid; (+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid; (+/-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid; (+/-)-2-Fluoro-alpha-methyl[1,1′ -biphenyl]-4-acetic Acid; (1)-2-Fluoro-alpha-methyl(1,1'-biphenyl)-4-acetic acid; 2-(2-Fluorobiphenyl-4-yl)propionic Acid; 2-(2-fluoro-[1,1'-biphenyl-4-yl])propanoic acid; 2-(2-fluorobiphenyl-4-yl)propanoic acid; 2-(3-fluoro-4-phenylphenyl)propanoic acid; 2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid; 2-Fluoro-alpha-methyl-4-biphenylacetic acid; 3-Fluoro-4-phenylhydratropic acid
                        
                     | ||||||||||||||||||||||||||
| Indication | 
 | ||||||||||||||||||||||||||
| Therapeutic Class | Antiinflammatory Agents | ||||||||||||||||||||||||||
| Drug Type | Small molecular drug | ||||||||||||||||||||||||||
| Structure |  | ||||||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||||||
List of Combinatorial Drugs (CBD) Containing This Drug
| 1 Investigative Drug Combination(s) Consisting of This drug Normalized Drug Combination Synergy Score Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons. 
 | ||||||||||||||||||||||||||||||||||||||||
| 4 Clinical Trial Drug Combination(s) Consisting of This drug 
 | ||||||||||||||||||||||||||||||||||||||||
References
